APREA THERAPEUTICS INC (APRE)

US03836J2015 - Common Stock

5.26  -0.09 (-1.68%)

After market: 5.31 +0.05 (+0.95%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
Revenue
583.23K0.000.000.000.00
Operating Expenses
16.06M113.39M37.45M52.81M29.54M
Research and Development
7.63M92.42M23.90M37.88M20.95M
Selling, General, and Administrative Expenses
8.43M20.97M13.55M14.93M8.59M
Operating Income
-15.47M-113.39M-37.45M-52.81M-29.54M
Interest Income/Expense
1.19M730.00K320.00K-670.00K1.48M
Income Before Taxes
-14.29M-112.66M-37.13M-53.48M-28.06M
Net Income
-14.29M-112.66M-37.13M-53.48M-28.06M
EBITDA
-15.46MN/A-37.44M-52.78M-29.53M
 
Per Share Data
EPS Diluted Total Ops
-3.95-67.86-35.02-50.45-26.72
Non GAAP EPS
-3.99-30.12-26.26-2.54N/A
 
Statistics
Profit Margin
-2449.59%N/AN/AN/AN/A
Operating Profit Margin
-2652.81%N/AN/AN/AN/A

All data in USD

Charts